- Filed
- May 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 13, 2024 | 18.26M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 19.02M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 12.18M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $0 |
| Capex | Q1 2024 · Mar 31, 2023 | $29K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$1.03M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $912K |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $8.62M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $11.48M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $44.14M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $48.12M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $8.57M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $8.61M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $25.73M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $26.14M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $9.72M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $12.09M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $34.35M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $37.61M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.15 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$0.33 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.15 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$0.33 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $1.55M |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $1.67M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$2.89M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$4.04M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$2.89M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$2.38M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | −$827K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $132K |
| Revenue | Q1 2024 · Mar 31, 2024 | $4.87M |
| Revenue | Q1 2024 · Mar 31, 2023 | $7.53M |